|
|||||
|
|
Similar efficacy and safety of dolutegravir between age groups of HIV‐1‐infected paediatric and young adult patients aged 5 years and older |
|
| Authors: | P Frange V Avettand‐Fenoel F Veber S Blanche |
| Abstract: | |
| Keywords: | adolescents children dolutegravir resistance virological failure |